Filename | DTG-ICWEA-STATEMENT2.pdf |
Filesize | 504.24 KB |
Version | 1 |
Date added | September 7, 2018 |
Downloaded | 1090 times |
Category | Press Statements |
Tags | aids, getting to zero, hiv prevention, reproductive health, tb, uganda, women |
slide_template | default |
World Health Organization (WHO) issued a statement on HIV antiretroviral drug Dolutegravir (DTG) following the identification of a potential safety issue related to neural tube defects in infants born to women living with HIV who were taking DTG at the time of conception in a study in Botswana. Shortly, the Ministry of Health in Uganda reviewed guidelines to exclude women 15-49 years from the use of DTG except for those on long term family planning methods and sterilization. Data from the Tsepamo Study show that 0.9% of babies (4 of 426 babies) who were exposed to Dolutegravir had neural tube defects. The neural tube defects were reported only in babies of some of the women who were taking Dolutegravir at the time of conception–there were no reported neural tube defects among more than 2,500 babies born to women who began taking Dolutegravir after conception. Read ICWEAs statement on DTG for women living with HIV of reproductive potential.
Good day!
I hope this email finds you well. My name is Nancy, a radio journalist working with a community/learning radio station in Kakamega, Western Kenya and I run a weekly radio programme on HIV and AIDS in conjuction with the AIDS CONTROL UNIT at my place of work; 103.9 MMUST FM.
I have read widely about your activities, and I am most interested to further know what you do, other activities that you undertake here in Kenya, and if there’s a way that your organization can incorporate radio journalists in your team to help spread your agenda. Especially those that produce programs in tandem with your agenda.
May I ask, do you have a network of journalists across the region that are able to help with your agenda? My interest lies with the possibility that I might be able to generate news stories from activities you undertake or positive broadcast programs to our listener-ship and much more.
Awaiting a positive response from you.
Kind Regards,
Nancy Imali
imalinancy@gmail.com/nogonyo@mmust.ac.ke
+254 725453916
Dear Nancy,
It is great to hear from you and we would definately like to work with you. Let us continue the conversation on email.
Thank you.